NOVOCURE LTD (NVCR) Earnings History & Surprises
NASDAQ:NVCR • JE00BYSS4X48
13.42 USD
+0.12 (+0.9%)
At close: Mar 4, 2026
13.42 USD
0 (0%)
After Hours: 3/4/2026, 5:38:57 PM
Past quarterly earnings results for NOVOCURE LTD (NVCR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateApr 20, 2026
PeriodQ1 / 2026
EPS Estimate-$0.50
Revenue Estimate171.22M
Last Reported
Release DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported-$0.22
EPS Surprise 47.58%
Revenue Surprise -1.40%
Beat Rate
88%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.22 | -0.42 | 47.58% | 63.93% | 174.35M | 176.82M | -1.40% | 8.11% |
| Q3 2025 | -0.33 | -0.43 | 23.15% | -17.86% | 167.204M | 162.37M | 2.98% | 7.81% |
| Q2 2025 | -0.36 | -0.39 | 8.12% | -16.13% | 158.805M | 157.29M | 0.96% | 5.62% |
| Q1 2025 | -0.31 | -0.47 | 34.54% | 13.89% | 154.994M | 149.54M | 3.65% | 11.91% |
| Q4 2024 | -0.61 | -0.35 | -73.92% | -35.56% | 161.266M | 160.97M | 0.18% | 20.54% |
| Q3 2024 | -0.28 | -0.34 | 17.78% | 39.13% | 155.095M | 146.83M | 5.63% | 21.81% |
| Q2 2024 | -0.31 | -0.42 | 26.08% | 42.59% | 150.356M | 138.54M | 8.53% | 19.28% |
| Q1 2024 | -0.36 | -0.43 | 16.51% | 28.00% | 138.503M | 134.08M | 3.30% | 13.36% |
| Q4 2023 | -0.45 | -0.53 | 15.39% | -25.00% | 133.784M | 133.81M | -0.02% | 4.19% |
| Q3 2023 | -0.46 | -0.54 | 14.10% | -84.00% | 127.321M | 131.34M | -3.06% | -2.81% |
| Q2 2023 | -0.54 | -0.51 | -5.80% | -134.78% | 126.051M | 126.74M | -0.54% | -10.54% |
| Q1 2023 | -0.50 | -0.33 | -51.47% | -1,150.00% | 122.182M | 129.82M | -5.88% | -11.14% |
| Q4 2022 | -0.36 | -0.31 | -15.72% | -44.00% | 128.4M | 130.82M | -1.85% | -3.60% |
| Q3 2022 | -0.25 | -0.27 | 6.25% | -92.31% | 131M | 132.68M | -1.27% | -1.95% |
| Q2 2022 | -0.23 | -0.15 | -55.51% | -64.29% | 140.9M | 137.69M | 2.33% | 5.54% |
| Q1 2022 | -0.04 | -0.18 | 78.21% | - | 137.5M | 136.76M | 0.54% | 2.08% |
| Q4 2021 | -0.25 | -0.10 | -141.64% | -725.00% | 133.2M | 139.81M | -4.73% | -7.50% |
| Q3 2021 | -0.13 | -0.08 | -72.81% | -244.44% | 133.6M | 144.05M | -7.25% | 0.68% |
| Q2 2021 | -0.14 | 0.01 | -1,643.92% | -800.00% | 133.5M | 144.73M | -7.76% | 15.19% |
| Q1 2021 | -0.04 | 0.02 | -296.08% | -200.00% | 134.7M | 142.15M | -5.24% | 32.32% |
| Q4 2020 | 0.04 | 0.13 | -68.49% | - | 144M | 144.12M | -0.08% | - |
| Q3 2020 | 0.09 | 0.03 | 164.73% | - | 132.7M | 122.42M | 8.40% | - |
| Q2 2020 | 0.02 | 0.00 | 622.88% | - | 115.9M | 108.15M | 7.17% | - |
| Q1 2020 | 0.04 | 0.02 | 82.99% | - | 101.8M | 104.19M | -2.29% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
-2.03%
Max EPS beat (4)
34.54%
Min EPS beat (4)
-73.92%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
1.94%
Max Revenue beat (4)
3.65%
Min Revenue beat (4)
0.18%
Analysis
In the last 4 quarters, NVCR has beaten EPS estimates in 3 out of 4 releases
NVCR has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, NVCR reported -2.0% below the EPS estimates on average.
In the last 4 quarters, NVCR has beaten the revenue estimates by 1.9% on average.
NOVOCURE LTD / NVCR Earnings FAQ
What is the most recent earnings date for NVCR stock?
NOVOCURE LTD (NVCR) last reported earnings on 2/26/2026.
Did NOVOCURE LTD (NVCR) beat earnings estimates last quarter?
NOVOCURE LTD (NVCR) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often NOVOCURE LTD beats earnings estimates?
In the last 4 quarters, NOVOCURE LTD (NVCR) has beaten EPS estimates in 3 out of 4 releases.